{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:08:51Z","timestamp":1792793331578,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.intimp.2025.114117","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T22:10:35Z","timestamp":1738275035000},"page":"114117","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Dapagliflozin alleviated seizures and cognition impairment in pilocarpine induced status epilepticus via suppressing microglia-mediated neuroinflammation and oxidative stress"],"prefix":"10.1016","volume":"148","author":[{"given":"Ying","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuling","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2343-8695","authenticated-orcid":false,"given":"Zhanhui","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10172","key":"10.1016\/j.intimp.2025.114117_b0005","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0140-6736(18)32596-0","article-title":"Epilepsy in adults","volume":"393","author":"Thijs","year":"2019","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.intimp.2025.114117_b0010","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1212\/WNL.0000000000003509","article-title":"Prevalence and incidence of epilepsy: a systematic review and meta-analysis of international studies","volume":"88","author":"Fiest","year":"2017","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.intimp.2025.114117_b0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00134-023-07263-w","article-title":"Status epilepticus in the ICU","volume":"50","author":"Rossetti","year":"2024","journal-title":"Intensive Care Med."},{"issue":"10","key":"10.1016\/j.intimp.2025.114117_b0020","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a022772","article-title":"Mechanisms responsible for cognitive impairment in epilepsy","volume":"5","author":"Lenck-Santini","year":"2015","journal-title":"Cold Spring Harb Perspect Med."},{"key":"10.1016\/j.intimp.2025.114117_b0025","doi-asserted-by":"crossref","unstructured":"Operto FF, Pastorino GMG, Viggiano A, Dell'Isola GB, Dini G, Verrotti A, Coppola G. Epilepsy and Cognitive Impairment in Childhood and Adolescence: A Mini-Review. Curr Neuropharmacol. 2023;21(8):1646-1665. doi: 10.2174\/1570159X20666220706102708.","DOI":"10.2174\/1570159X20666220706102708"},{"issue":"3","key":"10.1016\/j.intimp.2025.114117_b0030","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.tins.2012.11.008","article-title":"Glia and epilepsy: excitability and inflammation","volume":"36","author":"Devinsky","year":"2013","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.intimp.2025.114117_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2023.106249","article-title":"Microglia in epilepsy","volume":"185","author":"Yu","year":"2023","journal-title":"Neurobiol Dis."},{"issue":"8","key":"10.1016\/j.intimp.2025.114117_b0040","doi-asserted-by":"crossref","first-page":"743","DOI":"10.3390\/antiox9080743","article-title":"ROS generation in microglia: understanding oxidative stress and inflammation in neurodegenerative disease","volume":"9","author":"Simpson","year":"2020","journal-title":"Antioxidants (basel)."},{"issue":"1","key":"10.1016\/j.intimp.2025.114117_b0045","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3164\/jcbn.22-71","article-title":"Microglial inflammatory reactions regulated by oxidative stress","volume":"72","author":"Ishihara","year":"2023","journal-title":"J Clin Biochem Nutr."},{"issue":"1","key":"10.1016\/j.intimp.2025.114117_b0050","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s40035-020-00221-2","article-title":"Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes","volume":"9","author":"Kwon","year":"2020","journal-title":"Transl Neurodegener."},{"issue":"3","key":"10.1016\/j.intimp.2025.114117_b0055","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1124\/pr.120.019539","article-title":"Drug Resistance in Epilepsy: Clinical Impact, Potential Mechanisms, and New Innovative Treatment Options","volume":"72","author":"L\u00f6scher","year":"2020","journal-title":"Pharmacol Rev."},{"issue":"6","key":"10.1016\/j.intimp.2025.114117_b0060","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3892\/ijmm.2021.5052","article-title":"Semaglutide attenuates seizure severity and ameliorates cognitive dysfunction by blocking the NLR family pyrin domain containing 3 inflammasome in pentylenetetrazole\u2011kindled mice","volume":"48","author":"Wang","year":"2021","journal-title":"Int J Mol Med."},{"issue":"11","key":"10.1016\/j.intimp.2025.114117_b0065","first-page":"1094","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"374","author":"Zinman","year":"2016","journal-title":"N Engl J Med."},{"issue":"18","key":"10.1016\/j.intimp.2025.114117_b0070","first-page":"1800","article-title":"Empagliflozin and progression of kidney disease in type 2 diabetes","volume":"375","author":"Parving","year":"2016","journal-title":"N Engl J Med."},{"issue":"21","key":"10.1016\/j.intimp.2025.114117_b0075","first-page":"2099","article-title":"Canagliflozin and cardiovascular and renal events in type 2 diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"N Engl J Med."},{"issue":"9","key":"10.1016\/j.intimp.2025.114117_b0080","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S2213-8587(18)30141-4","article-title":"Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trials","volume":"6","author":"Perkovic","year":"2018","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.intimp.2025.114117_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115840","article-title":"Central administration of dapagliflozin alleviates a hypothalamic neuroinflammatory signature and changing tubular lipid metabolism in type 2 diabetic nephropathy by upregulating MCPIP1","volume":"168","author":"Da","year":"2023","journal-title":"Biomed Pharmacother."},{"issue":"3","key":"10.1016\/j.intimp.2025.114117_b0090","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1530\/JOE-17-0263","article-title":"Metabolic and neuroprotective effects of dapagliflozin and liraglutide in diabetic mice","volume":"234","author":"Millar","year":"2017","journal-title":"J Endocrinol."},{"issue":"1","key":"10.1016\/j.intimp.2025.114117_b0095","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1681\/ASN.2010030246","article-title":"SGLT2 mediates glucose reabsorption in the early proximal tubule","volume":"22","author":"Vallon","year":"2011","journal-title":"J Am Soc Nephrol."},{"issue":"10","key":"10.1016\/j.intimp.2025.114117_b0100","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1007\/s00125-018-4654-7","article-title":"Development of SGLT1 and SGLT2 inhibitors","volume":"61","author":"Rieg","year":"2018","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.intimp.2025.114117_b0105","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12883-018-1086-4","article-title":"Highly selective SGLT2 inhibitor dapagliflozin reduces seizure activity in pentylenetetrazol-induced murine model of epilepsy","volume":"18","author":"Erdogan","year":"2018","journal-title":"BMC Neurol."},{"key":"10.1016\/j.intimp.2025.114117_b0110","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.freeradbiomed.2017.01.035","article-title":"Dapagliflozin, a selective SGLT2 Inhibitor, attenuated cardiac fibrosis by regulating the macrophage polarization via STAT3 signaling in infarcted rat hearts","volume":"104","author":"Lee","year":"2017","journal-title":"Free Radic Biol Med."},{"issue":"333","key":"10.1016\/j.intimp.2025.114117_b0115","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.taap.2017.08.005","article-title":"SGLT2-inhibitor and DPP-4 inhibitor improve brain function via attenuating mitochondrial dysfunction, insulin resistance, inflammation, and apoptosis in HFD-induced obese rats","volume":"15","author":"Sa-Nguanmoo","year":"2017","journal-title":"Toxicol Appl Pharmacol."},{"issue":"11","key":"10.1016\/j.intimp.2025.114117_b0120","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3390\/ph13110379","article-title":"Perspective of SGLT2 inhibition in treatment of conditions connected to neuronal loss: focus on alzheimer's disease and ischemia-related brain injury","volume":"13","author":"Wici\u0144ski","year":"2020","journal-title":"Pharmaceuticals (Basel)"},{"issue":"3","key":"10.1016\/j.intimp.2025.114117_b0125","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1530\/JOE-17-0263","article-title":"Metabolic and neuroprotective effects of dapagliflozin and liraglutide in diabetic mice","volume":"234","author":"Millar","year":"2017","journal-title":"J Endocrinol."},{"issue":"11","key":"10.1016\/j.intimp.2025.114117_b0130","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3390\/ph13110379","article-title":"Perspective of SGLT2 inhibition in treatment of conditions connected to neuronal loss: focus on alzheimer's disease and ischemia-related brain injury","volume":"13","author":"Wici\u0144ski","year":"2020","journal-title":"Pharmaceuticals (Basel)"},{"issue":"5","key":"10.1016\/j.intimp.2025.114117_b0135","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/jcbfm.2015.32","article-title":"Striatal blood-brain barrier permeability in Parkinson's disease","volume":"35","author":"Gray","year":"2015","journal-title":"J Cereb Blood Flow Metab."},{"key":"10.1016\/j.intimp.2025.114117_b0140","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.yebeh.2016.05.026","article-title":"Inhibition of sodium glucose cotransporters following status epilepticus induced by intrahippocampal pilocarpine affects neurodegeneration process in hippocampus","volume":"61","author":"Melo","year":"2016","journal-title":"Epilepsy Behav."},{"issue":"19","key":"10.1016\/j.intimp.2025.114117_b0145","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.3390\/cells11193107","article-title":"Anti-Inflammatory properties of the SGLT2 inhibitor empagliflozin in activated primary microglia","volume":"11","author":"Heimke","year":"2022","journal-title":"Cells."},{"issue":"7","key":"10.1016\/j.intimp.2025.114117_b0150","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13653","article-title":"Neuroprotective effects of Canagliflozin: Lessons from aged genetically diverse UM-HET3 mice","volume":"21","author":"Jayarathne","year":"2022","journal-title":"Aging Cell"},{"issue":"8","key":"10.1016\/j.intimp.2025.114117_b0155","article-title":"Sodium-glucose Co-transporter-2 Inhibitor of dapagliflozin attenuates myocardial ischemia\/reperfusion injury by limiting NLRP3 inflammasome activation and modulating autophagy","volume":"10","author":"Yu","year":"2022","journal-title":"Front Cardiovasc Med."},{"issue":"1","key":"10.1016\/j.intimp.2025.114117_b0160","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0014-4886(03)00086-4","article-title":"Neuronal and glial pathological changes during epileptogenesis in the mouse pilocarpine model","volume":"182","author":"Borges","year":"2003","journal-title":"Exp Neurol."},{"issue":"9","key":"10.1016\/j.intimp.2025.114117_b0165","first-page":"10","article-title":"Effect of dapagliflozin on atherosclerosis and the mechanism related to sodium hydrogen exchanger 1","volume":"32","author":"Zhang","year":"2022","journal-title":"Chin J Comp Med."},{"issue":"1374","key":"10.1016\/j.intimp.2025.114117_b0170","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.brainres.2010.12.012","article-title":"Comparative neuroanatomical and temporal characterization of FluoroJade-positive neurodegeneration after status epilepticus induced by systemic and intrahippocampal pilocarpine in Wistar rats","volume":"16","author":"Castro","year":"2011","journal-title":"Brain Res."},{"issue":"7","key":"10.1016\/j.intimp.2025.114117_b0175","doi-asserted-by":"crossref","first-page":"10205","DOI":"10.1002\/jcp.27690","article-title":"miR-21 and miR-19b delivered by hMSC-derived EVs regulate the apoptosis and differentiation of neurons in patients with spinal cord injury","volume":"234","author":"Xu","year":"2019","journal-title":"J Cell Physiol."},{"issue":"1","key":"10.1016\/j.intimp.2025.114117_b0185","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/epi4.12560","article-title":"Different pharmacoresistance of focal epileptic spasms, generalized epileptic spasms, and generalized epileptic spasms combined with focal seizures","volume":"7","author":"Takahashi","year":"2022","journal-title":"Epilepsia Open."},{"issue":"Pt 1","key":"10.1016\/j.intimp.2025.114117_b0190","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/brain\/awh682","article-title":"Molecular and cellular mechanisms of pharmacoresistance in epilepsy","volume":"129","author":"Remy","year":"2006","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.intimp.2025.114117_b0195","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/ana.10692","article-title":"Chronic epilepsy and cognition: a longitudinal study in temporal lobe epilepsy","volume":"54","author":"Helmstaedter","year":"2003","journal-title":"Ann Neurol."},{"issue":"6","key":"10.1016\/j.intimp.2025.114117_b0200","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1046\/j.1468-1331.2001.00287.x","article-title":"The perception of memory failures in patients with epilepsy","volume":"8","author":"Piazzini","year":"2001","journal-title":"Eur J Neurol."},{"issue":"11","key":"10.1016\/j.intimp.2025.114117_b0205","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3390\/ph13110379","article-title":"Perspective of SGLT2 inhibition in treatment of conditions connected to neuronal loss: focus on alzheimer's disease and ischemia-related brain injury","volume":"13","author":"Wici\u0144ski","year":"2020","journal-title":"Pharmaceuticals (Basel)"},{"issue":"5","key":"10.1016\/j.intimp.2025.114117_b0210","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1007\/s43440-020-00143-w","article-title":"Role of oxidative stress in epileptogenesis and potential implications for therapy","volume":"72","author":"Borowicz-Reutt","year":"2020","journal-title":"Pharmacol Rep."},{"key":"10.1016\/j.intimp.2025.114117_b0215","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.neuropharm.2012.04.004","article-title":"The role of inflammation in epileptogenesis","volume":"69","author":"Vezzani","year":"2013","journal-title":"Neuropharmacology"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925001067?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925001067?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T16:12:51Z","timestamp":1740672771000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925001067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":42,"alternative-id":["S1567576925001067"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.114117","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dapagliflozin alleviated seizures and cognition impairment in pilocarpine induced status epilepticus via suppressing microglia-mediated neuroinflammation and oxidative stress","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.114117","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114117"}}